All Sauce from Weekly Sauce:

A study testing drugs that are used for other conditions for their potential in treating COVID-19 has found that the antidepressant fluvoxamine (brand name Luvox) offered no benefit, at least at an initial smaller dose. Study participants took 50 mg of the medication twice daily for 10 days, hoping to treat mild-to-moderate COVID-19 symptoms. A…  read on >  read on >

Alligators along North Carolina’s Cape Fear River have high blood levels of 14 toxic chemicals, along with signs of immune system damage, new research shows. The study of levels of per- and polyfluoroalkyls (PFAS) in the reptiles’ blood adds to concerns that the chemicals may cause genetic and immune system harm. Alligators are a sentinel…  read on >  read on >

The U.S. National Institutes of Health is investigating COVID experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a “killer” strain of the coronavirus as part of their research. Boston University is refuting those news accounts, calling them a “false and inaccurate” interpretation of its research.…  read on >  read on >

An older class of type 2 diabetes drugs known as thiazolidinediones, or TZDs, may protect you from dementia down the road, according to new research. Thiazolidinediones, also known as glitazones, cut dementia risk by 22% among folks at high risk who also had mild or moderate type 2 diabetes when they took these medications for…  read on >  read on >

It’s well known that Black women in the United States have an increased risk of childbirth complications. Now, a large new study finds even larger racial disparities when women conceive through infertility treatments. Researchers found that among U.S. women who’d undergone various infertility treatments, Black women had a substantially higher risk of losing their baby…  read on >  read on >